[1]文峰,苏永悦.息肉状脉络膜血管病变的新术语和非基于吲哚菁绿血管造影的诊断标准——2021亚太眼科影像学会专家共识解读与思考[J].眼科新进展,2022,42(6):421-426.[doi:10.13389/j.cnki.rao.2022.0086]
　WEN Feng,SU Yongyue.Interpretation of the consensus on nomenclature and non-indocyanine green angiograph based diagnostic criteria of polypoidal choroidal vasculopathy from the Asia-Pacific Ocular Imaging Society in 2021[J].Recent Advances in Ophthalmology,2022,42(6):421-426.[doi:10.13389/j.cnki.rao.2022.0086]
点击复制

息肉状脉络膜血管病变的新术语和非基于吲哚菁绿血管造影的诊断标准——2021亚太眼科影像学会专家共识解读与思考/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
42卷
期数:
2022年6期
页码:
421-426
栏目:
述评
出版日期:
2022-06-05

文章信息/Info

Title:
Interpretation of the consensus on nomenclature and non-indocyanine green angiograph based diagnostic criteria of polypoidal choroidal vasculopathy from the Asia-Pacific Ocular Imaging Society in 2021
作者:
文峰; 苏永悦
510060　广东省广州市，中山大学中山眼科中心，眼科学国家重点实验室，广东省眼科视觉科学重点实验室
Author(s):
WEN Feng; SU Yongyue
State Key Laboratory of Ophthalmology,Zhongshan Ophthalmic Center,Sun Yat-sen University,Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science,Guangzhou 510060，Guangdong Province,China
关键词:
息肉状脉络膜血管病变; 年龄相关性黄斑变性; 共识术语; 眼底影像; 吲哚菁绿血管造影; 光学相干断层扫描
Keywords:
polypoidal choroidal vasculopathy;  age-related macular degeneration;  consensus on nomenclature;  fundus imaging;  indocyanine green angiography;  optical coherence tomography
分类号:
R773.4
DOI:
10.13389/j.cnki.rao.2022.0086
文献标志码:
A
摘要:
息肉状脉络膜血管病变（PCV）发现之初至今的40年间，其命名和各成分术语随着眼底影像技术的飞速发展不断更迭，部分常用术语已经无法代表PCV病灶的本质；同时，以无创的检查手段诊断PCV的效能越来越受到关注。2021年，亚太眼科影像学会PCV工作组讨论并针对PCV两个重要成分的术语做出专家共识，并提出一套不基于吲哚菁绿眼底血管造影的PCV诊断标准，以期鉴别PCV与典型的新生血管性年龄相关性黄斑变性。该共识是对影像学和组织学报告的最新理解的凝练，概念明晰且精炼，值得临床推广应用。
Abstract:
Over the past 40 years from the discovery of polypoidal choroidal vasculopathy (PCV), the fundus imaging technology has developed rapidly, and with the in-depth research, the terminology of PCV components has changed accordingly. Some commonly used terms have been unable to represent the essence of PCV lesions. The efficacy of the noninvasive examination in PCV diagnosis has attracted more and more attention. In 2021, the PCV Workgroup of the Asia-Pacific Ocular Imaging Society discussed and reached a consensus on the nomenclature of the two important components of PCV, and proposed a set of PCV diagnostic criteria not based on indocyanine green angiography to distinguish PCV from typical neovascular age-related macular degeneration. The consensus is an accurate summary of the latest imaging and histological reports, worthy of clinical application.

参考文献/References:

［1］　WONG C W,YANAGI Y,LEE W K,OGURA Y A,WONG T Y,CHEUNG C M.Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians［J］.Prog Retin Eye Res,2016,53:107-139.
［2］　CHEUNG C M G,LAI T Y Y,TEO K T,RUAMVIBOONSUK P,CHEN S J,KIM J E,et al.Polypoidal choroidal vasculopathy:consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the asia-pacific ocular imaging society PCV workgroup［J］.Ophthalmology,2021,128(3):443-452.
［3］　YANNUZZI L A.Idiopathic polypoidal choroidal vasculopathy［C］.Miami:Macula Society Meeting,1982.
［4］　STERN R M,ZAKOV Z N,ZEGARRA H,GUTMAN F.Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women［J］.Am J Ophthalmol,1985,100(4):560-569.
［5］　KLEINER R C,BRUCKER A J,JOHNSTON R L.The posterior uveal bleeding syndrome［J］.Retina,1990,10(1):9-17.
［6］　YANNUZZI L A,SORENSON J,SPAIDE R F,LIPSON B.Idiopathic polypoidal choroidal vasculopathy (IPCV)［J］.Retina,1990,10(1):1-8.
［7］　SPAIDE R F,YANNUZZI L A,SLAKTER J S,SORENSON J,ORLACH D A.Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy［J］.Retina,1995,15(2):100-110.
［8］　LAUDE A,CACKETT P D,VITHANA E N,YEO I Y,WONG D,KOH A H,et al.Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration:same or different disease?［J］.Prog Retin Eye Res,2010,29(1):19-29.
［9］　COSCAS G,YAMASHIRO K,COSCAS F,DE BENEDETTO U,TSUJIKAWA A,MIYAKE M,et al.Comparison of exudative age-related macular degeneration subtypes in Japanese and French patients:multicenter diagnosis with multimodal imaging［J］.Am J Ophthalmol,2014,158(2):309-318.
［10］　文峰.特发性息肉状脉络膜血管病变的临床分析［R］.大连:第九届全国眼底病年会,2001.
WEN F.Clinical analysis of idiopathic polypoid choroidal angiopathy［C］.Dalian:the 9th National Annual Meeting on Fundus Diseases, 2001.
［11］　WEN F,CHEN C,WU D,LI H.Polypoidal choroidal vasculopathy in elderly Chinese patients［J］.Graefes Arch Clin Exp Ophthalmol,2004,242(8):625-629.
［12］　姜利斌,文峰,吴乐正.特发性息肉状脉络膜血管病变［J］.中华眼底病杂志,2002,18(4):61-63.
JIANG L B,WEN F,WU L Z.Idiopathic polypoid choroidal angiopathy［J］.Chin J Ocul Fundus Dis,2002,18(4):61-63.
［13］　文峰,吴德正,李海涛,黄时洲,罗光伟,刘彩娇,等.息肉状脉络膜血管病变的眼底特征分析［J］.中华眼底病杂志,2003,19(5):4-7.
WEN F,WU D Z,LI H T,HUANG S Z,LUO G W,LIU C J,et al.Analysis of fundus characteristics of polypoid choroidal angiopathy ［J］.Chin J Ocul Fundus Dis,2003,19(5):4-7.
［14］　LIU Y,WEN F,HUANG S,LUO G,YAN H,SUN Z,et al.Subtype lesions of neovascular age-related macular degeneration in Chinese patients［J］.Graefes Arch Clin Exp Ophthalmol,2007,245(10):1441-1445.
［15］　ALSHAHRANI S T,SHAMSI H N A,KAHTANI E S,GHAZI N G.Spectral-domain optical coherence tomography findings in polypoidal choroidal vasculopathy suggest a type 1 neovascular growth pattern［J］.Clin Ophthalmol,2014,8:1689-1695.
［16］　OJIMA Y,HANGAI M,SAKAMOTO A,TSUJIKAWA A,OTANI A,TAMURA H,et al.Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography［J］.Retina,2009,29(1):52-59.
［17］　CHEUNG C,LAI T,RUAMVIBOONSUK P,CHEN S J,CHEN Y,FREUND K B,et al.Polypoidal choroidal vasculopathy:definition,pathogenesis,diagnosis,and management［J］.Ophthalmology,2018,125(5):708-724.
［18］　TOMIYASU T,NOZAKI M,YOSHIDA M,OGURA Y.Characteristics of polypoidal choroidal vasculopathy evaluated by optical coherence tomography angiography［J］.Invest Ophthalmol Vis Sci,2016,57(9):T324-T330.
［19］　CHEUNG C,YANAGI Y,MOHLA A,LEE S Y,MATHUR R,CHAN C M,et al.Characterization and differentiation of polypoidal choroidal vasculopathy using swept source optical coherence tomography angiography［J］.Retina,2017,37(8):1464-1474.
［20］　KIM J Y,KWON O W,OH H S,KIM S H,YOU Y S.Optical coherence tomography angiography in patients with polypoidal choroidal vasculopathy［J］.Graefes Arch Clin Exp Ophthalmol,2016,254(8):1505-1510.
［21］　INOUE M,BALARATNASINGAM C,FREUND K B.Optical coherence tomography angiography of polypoidal choroidal vasculopathy and polypoidal choroidal neovascularization［J］.Retina,2015,35(11):2265-2274.
［22］　KIM K,YANG J,FEUER W,GREGORI G,KIM E S,ROSENFELD P J,et al.A comparison study of polypoidal choroidal vasculopathy imaged with indocyanine green angiography and Swept-Source optical coherence tomography angiography［J］.Am J Ophthalmol,2020,217:240-251.
［23］　FUJITA A,KATAOKA K,TAKEUCHI J,NAKANO Y,HORIGUCHI E,KANEKO H,et al.Diagnostic characteristics of polypoidal choroidal vasculopathy based on B-scan Swept-Source optical coherence tomography angiography and its interrater agreement compared with indocyanine green angiography［J］.Retina,2020,40(12):2296-2303.
［24］　CHEUNG C,YANAGI Y,AKIBA M,TAN A,MATHUR R,CHAN C M,et al.Improved detection and diagnosis of polypoidal choroidal vasculopathy using a combination of optical coherence tomography and optical coherence tomography angiography［J］.Retina,2019,39(9):1655-1663.
［25］　PEIRETTI E,IOVINO C,SACCONI R,CAMINITI G,QUERQUES G.Optical coherence tomography angiography characteristics of polypoidal choroidal vasculopathy secondary to chronic central serous chorioretinopathy［J］.Retina,2019,39(9):1693-1700.
［26］　WANG M,ZHOU Y,GAO S S,LIU W,HUANG Y,HUANG D,et al.Evaluating polypoidal choroidal vasculopathy with optical coherence tomography angiography［J］.Invest Ophthalmol Vis Sci,2016,57(9):OCT526-OCT532.
［27］　CHAN S Y,WANG Q,WANG Y X,SHI X H,JONAS J B,WEI W B.Polypoidal choroidal vasculopathy upon optical coherence tomography angiography［J］.Retina,2018,38(6):1187-1194.
［28］　SEONG S,CHOO H G,KIM Y J,KIM J Y,LEE J H,OH H S,et al.Novel findings of polypoidal choroidal vasculopathy via optical coherence tomography angiography［J］.Korean J Ophthalmol,2019,33(1):54-62.
［29］　BO Q,YAN Q,SHEN M,SONG M,SUN M,YU Y,et al.Appearance of polypoidal lesions in patients with polypoidal choroidal vasculopathy using Swept-Source optical coherence tomographic angiography［J］.JAMA Ophthalmol,2019,137(6):642-650.
［30］　CACKETT P,WONG D,YEO I.A classification system for polypoidal choroidal vasculopathy［J］.Retina,2009,29(2):187-191.
［31］　YANNUZZI L A,WONG D W,SFORZOLINI B S,GOLDBAUM M,TANG K C,SPAIDER F,et al.Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration［J］.Arch Ophthalmol,1999,117(11):1503-1510.
［32］　ZENG R,ZHANG X,LI M,WEN F.Pilot study of inactive polypoidal lesions in polypoidal choroidal vasculopathy［J］.Eur J Ophthalmol,2015,25(3):222-228.
［33］　KOH A,LEE W K,CHEN L J,CHEN S J,HASHAD Y,KIM H,et al.Everest study:efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy［J］.Retina,2012,32(8):1453-1464.
［34］　KAWAMURA A,YUZAWA M,MORI R,HARUYAMA M,TANAKA K.Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types［J］.Acta Ophthalmol,2013,91(6):e474-e481.
［35］　TAN C S,NGO W K,LIM L W,LIM T H.A novel classification of the vascular patterns of polypoidal choroidal vasculopathy and its relation to clinical outcomes［J］.Br J Ophthalmol,2014,98(11):1528-1533.
［36］　BYEON S H,LEW Y J,LEE S C,KWON O W.Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy［J］.Acta Ophthalmol,2010,88(6):660-668.
［37］　SASAHARA M,TSUJIKAWA A,MUSASHI K,GOTOH N,OTANI A,MANDAI M,et al.Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability［J］.Am J Ophthalmol,2006,142(4):601-607.
［38］　GUPTA P,TING D,THAKKU S G,WONG T Y,CHENG C Y,WONG E,et al.Detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy［J］.Retina,2017,37(12):2269-2280.
［39］　KOIZUMI H,YAMAGISHI T,YAMAZAKI T A.Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability［J］.Am J Ophthalmol,2013,155(2):305-313.
［40］　LIU B,ZHANG X,MI L,PENG Y,WEN F.Choroidal structure in subtypes of polypoidal choroidal vasculopathy determined by binarization of optical coherence tomographic images［J］.Clin Exp Ophthalmol,2019,47(5):631-637.
［41］　CHEN L,ZHANG X,LIU B,LAN M,WEN F.Age-related scattered hypofluorescent spots on late-phase indocyanine green angiography:the multimodal imaging and relevant factors［J］.Clin Exp Ophthalmol,2018,46(8):908-915.
［42］　CHEN L,ZHANG X,LI M,GAN Y,WEN F.Drusen and age-related scattered hypofluorescent spots on late-phase indocyanine green angiography,a candidate correlate of lipid accumulation［J］.Invest Ophthalmol Vis Sci,2018,59(12):5237-5245.
［43］　CURCIO C A,MILLICAN C L.Basal linear deposit and large drusen are specific for early age-related maculopathy［J］.Arch Ophthalmol,1999,117(3):329-339.
［44］　CURCIO C A,JOHNSON M,HUANG J D,RUDOLF M.Aging,age-related macular degeneration,and the response-to-retention of apolipoprotein B-containing lipoproteins［J］.Prog Retin Eye Res,2009,28(6):393-422.
［45］　GOLDBAUM M,TANG K C,SPAIDER F,CHEN L,ZHANG X,LI M,LIAO N,WEN F.Age-related scattered hypofluorescent spots on late-phase indocyanine green angiography as precursor lesions of polypoidal choroidal vasculopathy［J］.Invest Ophthalmol Vis Sci,2019,60(6):2102-2109.
［46］　DANSINGANI K K,GALOR O,SADDA S R,YANNUZZI L A,FREUND K B.Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy):a lesson in the taxonomy of expanded spectra:a review［J］.Clin Exp Ophthalmol,2018,46(2):189-200.
［47］　LI M,DOLZ-MARCO R,MESSINGER J D,SLOAN K R,FERRARA D,CURCIO C A,et al.Clinicopathologic correlation of aneurysmal type 1 neovascularization in age-related macular degeneration［J］.Ophthalmol Retina,2019,3(2):99-111.
［48］　OKUBO A,SAMESHIMA M,UEMURA A,KANDA S,OHBA N.Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study［J］.Br J Ophthalmol,2002,86(10):1093-1098.
［49］　TRANOS P,VACALIS A,ASTERIADIS S,KOUKOULA S,VACHTSEVANOS A,PERGANTA G,et al.Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration［J］.Drug Des Devel Ther,2013,7:485-490.
［50］　DE SALVO G,VAZ-PEREIRA S,KEANE P A,LIEW G.Sensitivity and specificity of Spectral-Domain optical coherence tomography in detecting idiopathic polypoidal choroidal vasculopathy［J］.Am J Ophthalmol,2014,158(6):1228-1238.
［51］　LIU R,LI J Q,LI Z J,YU S S,YANG Y,YAN H,et al.Distinguishing polypoidal choroidal vasculopathy from typical neovascular age-related macular degeneration based on spectral domain optical coherence tomography［J］.Retina,2016,36(4):778-786.
［52］　CHAIKITMONGKOL V,KONG J,KHUNSONGKIET P,PATIKULSILA D,SACHDEVA M,CHAVENGSAKSONGKRAM P,et al.Sensitivity and specificity of potential diagnostic features detected using fundus photography,optical coherence tomography,and fluorescein angiography for polypoidal choroidal vasculopathy［J］.JAMA Ophthalmol,2019,137(6):661-667.

相似文献/References:

[1]范姜砾 王雨生 张鹏.湿性年龄相关性黄斑变性患者血浆中相关抗氧化酶水平测定[J].眼科新进展,2012,32(5):000.
[2]刘延东.息肉状脉络膜血管病变眼底影像检查特征[J].眼科新进展,2012,32(12):000.
[3]王毅 李罗翔 李娟 曾庆华.ApoE基因缺失小鼠视网膜及Bruch膜组织形态观察[J].眼科新进展,2013,33(1):000.
[4]徐新荣 仲路 黄冰林 魏源华 周欣 王玲 王富强.年龄相关性黄斑变性血浆蛋白质组学初步研究[J].眼科新进展,2013,33(2):000.
[5]党亚龙 陈彬川 穆雅林 赵满丽 朱豫.i-MP对产生2型脉络膜新生血管的年龄相关性黄斑变性患者视力及黄斑厚度的影响[J].眼科新进展,2013,33(2):000.
[6]王毅 李罗翔 李进辉 李娟 曾庆华.血脂异常ApoE基因缺失小鼠视网膜色素上皮细胞胞浆内黑色素和脂褐素的改变[J].眼科新进展,2013,33(7):000.
[7]罗文婷 孙大卫.血管黏附蛋白-1在眼科疾病中的研究进展[J].眼科新进展,2013,33(8):000.
[8]陆秉文 吴星伟.光动力疗法治疗年龄相关性黄斑变性的研究进展[J].眼科新进展,2013,33(4):000.
[9]栾兰 姚勇.湿性年龄相关性黄斑变性的治疗进展[J].眼科新进展,2013,33(4):000.
[10]胡艳红 祁明信 郭娜 陈胜 柯发杰.渗出型年龄相关性黄斑变性患者外周血CCR3的表达[J].眼科新进展,2013,33(11):000.

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81870674）
更新日期/Last Update: 2022-06-05